| 5V71: reference: KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry., Lu J, Harrison RA, Li L, Zeng M, Gondi S, Scott D, Gray NS, Engen JR, Westover KD, Structure. 2017 Jul 25. pii: S0969-2126(17)30218-6. doi:, 10.1016/j.str.2017.07.003. PMID: 28781083 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).